Losartan Potassium
Product Images NDC 68645-526

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68645-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharmaceutical Packaging, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Losartan Potassium Tablets Lupin 1)

Chemical structure diagram of Losartan Potassium, showing its molecular components including chlorine, potassium ion, and aromatic rings.*

FDA Label Image

Image (Losartan Potassium Tablets Lupin 2)

A line graph comparing the percentage of patients with a primary endpoint over study months between Losartan and Atenolol. The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients with the primary endpoint, ranging from 0 to 16%. The graph includes a note on adjusted risk reduction of 13% with a p-value of 0.021.*

FDA Label Image

Figure 6 (Losartan Potassium Tablets Lupin 3)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months for Atenolol and Losartan. The graph shows two trend lines, with Atenolol represented by a dotted line and Losartan by a solid line, demonstrating adjusted risk reduction associated with Losartan at 25% (p=0.001). The x-axis denotes study months from 0 to 66, and the y-axis indicates the percentage of patients from 0 to 8%.*

FDA Label Image

Figure 7 (Losartan Potassium Tablets Lupin 4)

A figure titled 'Primary Endpoint Events within Demographic Subgroups' showing two forest plots comparing Losartan and Atenolol. The left plot shows the Primary Composite endpoint with hazard ratios and confidence intervals across subgroups like age, gender, race, ISH, diabetes, and history of cardiovascular disease. The right plot presents data on Stroke (fatal/non-fatal) events with similar subgroup analysis. Symbols vary by sample size, and the plots indicate whether Losartan or Atenolol is favored for each subgroup.*

FDA Label Image

Image 2 (Losartan Potassium Tablets Lupin 5)

A line graph comparing the percentage of patients with an event over 48 months between Losartan and placebo groups. The graph shows risk reduction of 16.1% with a p-value of 0.022. The x-axis represents months, and the y-axis represents the percentage of patients with events, with Losartan depicted by a solid line and placebo by a dashed line.*

FDA Label Image

Losartan Potassium Tablets Usp 25mg (Losartan Potassium Tablets Lupin 6)

Packaging label for Losartan Potassium Tablets USP 25 mg, distributed by Legacy Pharmaceutical Packaging, LLC. The label indicates a child-resistant package with 30 tablets. It includes package opening instructions with images for pushing, pressing, holding, and pulling to open the blister pack. The label also features Walmart branding and a barcode.*

FDA Label Image

Losartan Potassium Tablets Usp 50mg (Losartan Potassium Tablets Lupin 7)

Packaging label for Losartan Potassium Tablets USP 50 mg, 30 tablets per bottle. The label displays dosage strength, child-resistant package opening instructions, and includes Walmart branding with a website for online refills. The tablets are white, oval, and imprinted with 'LIU' and 'P22'. Manufacturer noted as Legacy Pharmaceutical Packaging, LLC, Earth City, MO.*

FDA Label Image

Losartan Potassium Tablets Usp 100mg (Losartan Potassium Tablets Lupin 8)

Losartan Potassium Tablets USP 100 mg packaging label from Legacy Pharmaceutical Packaging, LLC, containing 30 tablets. The label includes dosage strength, child-resistant package instructions illustrated on the label, and a barcode. It features a blue, white, and red design with Walmart branding and directions for opening the child-resistant blister pack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.